ReportEfficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis
Section snippets
Acknowledgements
We would like to acknowledge Ms. Kaitlin Fuller, librarian at Gerstein Science Information Centre at the University of Toronto, Toronto, Ontario, Canada, for her tremendous guidance with establishing our search strategy for the project.
References (7)
- et al.
Comparative study of infliximab versus adalimumab in refractory uveitis due to Behçet’s disease: national multicenter study of 177 cases
Arthritis Rheumatol
(2019) - et al.
Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis
J Rheumatol
(2018) - et al.
Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement
BMJ
(2009)
Cited by (2)
Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis
2024, Expert Opinion on Investigational DrugsSuccessful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet’s Uveitis
2023, Ocular Immunology and Inflammation
Disclosure(s) No financial support was received for this study.
All authors have completed and submitted the ICMJE disclosures form.
The author(s) have made the following disclosure(s): L.A.D.-D.: Financial support – AbbVie, Novartis, Allergan. T.F.: Grants – Fighting Blindness Canada, Vanier Canada Graduate Scholarship, Canada Graduate Scholarship-Masters, the Vision Science Research Program, and Postgraduate Medical Education Research Awards as part of postsecondary research funding.
HUMAN SUBJECTS: No human subjects were included in this study. The requirement for informed consent was waived because of the retrospective nature of the study. All research adhered to the tenets of the Declaration of Helsinki.
No animal subjects were included in this study.
Author Contributions:
Conception and design: Tai, Far, Ramsay, Sander, Derzko-Dzulynsky, Felfeli
Analysis and interpretation: Tai, Far, Pechlivanoglou, Georgakopoulos, Felfeli
Data collection: Tai, Far, Felfeli
Obtained funding: Felfeli
Overall responsibility: Tai, Far, Pechlivanoglou, Ramsay, Georgakopoulos, Sander, Derzko-Dzulynsky, Felfeli